Your browser doesn't support javascript.
loading
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Sidana, Surbhi; Peres, Lauren C; Hashmi, Hamza; Hosoya, Hitomi; Ferreri, Christopher; Khouri, Jack; Dima, Danai; Atrash, Shebli; Voorhees, Peter; Simmons, Gary; Sborov, Douglas W; Kalariya, Nilesh; Hovanky, Vanna; Bharadwaj, Sushma; Miklos, David; Wagner, Charlotte; Kocoglu, Mehmet H; Kaur, Gurbakhash; Davis, James A; Midha, Shonali; Janakiram, Murali; Freeman, Ciara; Alsina, Melissa; Locke, Frederick; Gonzalez, Rebecca; Lin, Yi; McGuirk, Joseph; Afrough, Aimaz; Shune, Leyla; Patel, Krina K; Hansen, Doris K.
Afiliação
  • Sidana S; Stanford University School of Medicine. Surbhi.Sidana@stanford.edu.
  • Peres LC; H. Lee Moffitt Cancer Center and Research Institute.
  • Hashmi H; Medical University of South Carolina.
  • Hosoya H; Stanford University School of Medicine.
  • Ferreri C; The University of Texas MD Anderson Cancer Center.
  • Khouri J; Cleveland Clinic Taussig Cancer Center.
  • Dima D; Cleveland Clinic Taussig Cancer Center.
  • Atrash S; Levine Cancer Institute.
  • Voorhees P; Levine Cancer Institute.
  • Simmons G; Virginia Commonwealth University Massey Cancer Center.
  • Sborov DW; The University of Utah Huntsman Cancer Institute.
  • Kalariya N; The University of Texas MD Anderson Cancer Center.
  • Hovanky V; Stanford University School of Medicine.
  • Bharadwaj S; Stanford University School of Medicine.
  • Miklos D; Stanford University School of Medicine.
  • Wagner C; The University of Utah Huntsman Cancer Institute.
  • Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
  • Kaur G; UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
  • Davis JA; Medical University of South Carolina.
  • Midha S; Dana Farber Cancer Institute.
  • Janakiram M; City of Hope Cancer Center.
  • Freeman C; H. Lee Moffitt Cancer Center and Research Institute.
  • Alsina M; H. Lee Moffitt Cancer Center and Research Institute.
  • Locke F; H. Lee Moffitt Cancer Center and Research Institute.
  • Gonzalez R; H. Lee Moffitt Cancer Center and Research Institute.
  • Lin Y; Mayo Clinic, Rochester.
  • McGuirk J; The University of Kansas Medical Center.
  • Afrough A; UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
  • Shune L; The University of Kansas Medical Center.
  • Patel KK; The University of Texas MD Anderson Cancer Center.
  • Hansen DK; H. Lee Moffitt Cancer Center and Research Institute. Doris.Hansen@moffitt.org.
Haematologica ; 109(3): 777-786, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37731379
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal / Neoplasias de Plasmócitos / Receptores de Antígenos Quiméricos / Citopenia / Mieloma Múltiplo Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal / Neoplasias de Plasmócitos / Receptores de Antígenos Quiméricos / Citopenia / Mieloma Múltiplo Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article